{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:00:52Z","timestamp":1769281252831,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Egyptian Russian University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Medication compliance is a key factor in achieving positive health outcomes, and this is difficult for patients, especially the elderly, who need polytherapy. Therefore, pharmacy experts have devised a single-pill combination that combines more than one active pharmaceutical ingredient to treat multiple diseases and improve patient compliance with medication. Here, an affordable UPLC approach was designed for the estimation of a fixed-dose combination that cures hypertension, hyperlipidemia, and blood coagulation and subsequently prevents heart attacks. This combination includes four active ingredients: aspirin (ASR), atorvastatin calcium (ATC), metoprolol succinate (MES), and ramipril (RAP). The applied approach was devised to determine the mentioned drugs in their commercial dosage form and also in the presence of ASR\u2019s impurity (salicylic acid) and ATC\u2019s impurity (aniline). The target drugs were separated on a Kinetex\n                    <jats:sup>\u00ae<\/jats:sup>\n                    XB-C18 column using an isocratic micellar eluent system composed of 0.02\u00a0M Brij-35 at pH 3.0 (using orthophosphoric acid) and 10% n-propanol, flowed at 0.20 mL\/min. The mentioned drugs were UV-scanned at 230.0\u00a0nm. ICH requirements were followed for all validation items. Whiteness and greenness appraisals were performed, affirming the applied approach\u2019s friendliness to the environment. The priority of this UPLC approach over the published LC ones is due to using a micellar moving phase, making it more eco-friendly to the environment, and the determination of the aforementioned drugs even in the presence of aniline (toxic impurity) and salicylic acid.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-27968-w","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:16:35Z","timestamp":1769112995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Towards sustainable pharmaceutical QC: micellar-UPLC strategy for concomitant analysis of a cardiovascular polypill with aniline and salicylic acid impurities"],"prefix":"10.1038","volume":"16","author":[{"given":"Ahmed R.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israa M.","family":"Nour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Badrawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Darweish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"27968_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills, K. T., Stefanescu, A. & He, J. The global epidemiology of hypertension, nature reviews. Nat. Rev. Nephrol. 16, 223\u2013237 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"27968_CR2","unstructured":"Feingold, K. R. in Guidelines for the Management of High Blood Cholesterol. (eds Endotext) (MDText.com, Inc., 2025)."},{"key":"27968_CR3","doi-asserted-by":"publisher","first-page":"212531","DOI":"10.7573\/dic.212531","volume":"7","author":"C Guerrero-Garc\u00eda","year":"2018","unstructured":"Guerrero-Garc\u00eda, C. & Rubio-Guerra, A. F. Combination therapy in the treatment of hypertension. Drugs Context. 7, 212531 (2018).","journal-title":"Drugs Context"},{"key":"27968_CR4","doi-asserted-by":"crossref","unstructured":"Martinez-Hervas, S., Ascaso, J. F. & Hypercholesterolemia Encyclopedia Endocr. Dis. 320\u2013326. (2023).","DOI":"10.1016\/B978-0-12-801238-3.65340-0"},{"key":"27968_CR5","doi-asserted-by":"publisher","first-page":"204062232211027","DOI":"10.1177\/20406223221102754","volume":"13","author":"R Sarzani","year":"2022","unstructured":"Sarzani, R., Laureti, G., Gezzi, A., Spannella, F. & Giulietti, F. Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient. Therapeutic Adv. Chronic Disease. 13, 20406223221102750 (2022).","journal-title":"Therapeutic Adv. Chronic Disease"},{"key":"27968_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","volume":"110","author":"JR Vane","year":"2003","unstructured":"Vane, J. R. & Botting, R. M. The mechanism of action of aspirin. Thromb. Res. 110, 255\u2013258 (2003).","journal-title":"Thromb. Res."},{"key":"27968_CR7","doi-asserted-by":"crossref","unstructured":"Kurata, T., Deguchi, K., Deguchi, S., Ikeda, Y. & Abe, K. Statins and reduction of oxidative stress in the aged brain, Diet and Nutrition in Dementia and Cognitive Decline. 753\u2013760. (2015).","DOI":"10.1016\/B978-0-12-407824-6.00069-0"},{"key":"27968_CR8","doi-asserted-by":"crossref","unstructured":"Davis, S. Ramipril, XPharm: The comprehensive pharmacology reference. 1\u20136. (2007).","DOI":"10.1016\/B978-008055232-3.62512-7"},{"key":"27968_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s40256-017-0221-8","volume":"17","author":"CA D\u00e9zsi","year":"2017","unstructured":"D\u00e9zsi, C. A. & Szentes, V. The real role of \u03b2-blockers in daily cardiovascular therapy. Am. J. Cardiovasc. Drugs. 17, 361\u2013373 (2017).","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"27968_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijpharm.2004.11.032","volume":"292","author":"SJ Bashir","year":"2005","unstructured":"Bashir, S. J. et al. Cutaneous bioassay of Salicylic acid as a keratolytic. Int. J. Pharm. 292, 187\u2013194 (2005).","journal-title":"Int. J. Pharm."},{"key":"27968_CR11","unstructured":"United States Pharmacopeia. and National Formulary (USP 46\u2013NF 41), Aspirin Tablets Monograph, United States Pharmacopeial Convention, Rockville, MD, USA."},{"key":"27968_CR12","unstructured":"Aniline - CargoHandbook - the world\u2019s largest cargo transport guidelines website, (2024)."},{"key":"27968_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2174\/1570159X16666180803164238","volume":"17","author":"P Makhdoumi","year":"2018","unstructured":"Makhdoumi, P., Hossini, H., Ashraf, G. M. & Limoee, M. Molecular mechanism of aniline induced spleen toxicity and neuron toxicity in experimental rat exposure: A review. Curr. Neuropharmacol. 17, 201\u2013213 (2018).","journal-title":"Curr. Neuropharmacol."},{"key":"27968_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1515\/acph-2016-0040","volume":"66","author":"SA Hassan","year":"2016","unstructured":"Hassan, S. A., Elzanfaly, E. S., Salem, M. Y. & El-Zeany, B. A. Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and Atorvastatin in the presence of their acidic degradation products in tablets. Acta Pharm. 66, 479\u2013490 (2016).","journal-title":"Acta Pharm."},{"key":"27968_CR15","doi-asserted-by":"publisher","first-page":"2200695","DOI":"10.1002\/jssc.202200695","volume":"46","author":"E Darweish","year":"2023","unstructured":"Darweish, E., Marzouk, H. M., Fayez, Y. M. & Eissa, M. S. Ecofriendly chromatographic Estimation of spasmolytic pharmaceutical mixture along with official toxic impurity, 3,5-dichloroaniline: complete green profile appraisal. J. Sep. Sci. 46, 2200695 (2023).","journal-title":"J. Sep. Sci."},{"key":"27968_CR16","first-page":"87","volume":"16","author":"I Cok","year":"2012","unstructured":"Cok, I. & Emerce, E. Overview of impurities in pharmaceuticals: toxicological aspects. Asian Chem. Lett. 16, 87\u201397 (2012).","journal-title":"Asian Chem. Lett."},{"key":"27968_CR17","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.4155\/bio-2021-0183","volume":"13","author":"E Darweish","year":"2021","unstructured":"Darweish, E., Eissa, M. S., Fayez, Y. M. & Marzouk, H. M. Chromatographic Estimation of a novel triple-therapy combination targeting Helicobacter pylori eradication in different matrices. Bioanalysis 13, 1547\u20131557 (2021).","journal-title":"Bioanalysis"},{"key":"27968_CR18","first-page":"156","volume":"3","author":"O Coskun","year":"2016","unstructured":"Coskun, O. Separation techniques: chromatography. North. Clin. Istanbul. 3, 156\u2013160 (2016).","journal-title":"North. Clin. Istanbul"},{"key":"27968_CR19","doi-asserted-by":"crossref","unstructured":"Mallik, B., Chakravarti, B. & Chakravarti, D. N. Principles of chromatography, Current Protocols Essential Laboratory Techniques. 13 6.1.1\u20136.1.23. (2016).","DOI":"10.1002\/cpet.7"},{"key":"27968_CR20","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1002\/jssc.200600147","volume":"29","author":"L Nov\u00e1kov\u00e1","year":"2006","unstructured":"Nov\u00e1kov\u00e1, L., Solichov\u00e1, D. & Solich, P. Advantages of ultra-performance liquid chromatography over high-performance liquid chromatography: comparison of different analytical approaches during analysis of diclofenac gel. J. Sep. Sci. 29, 2433\u20132443 (2006).","journal-title":"J. Sep. Sci."},{"key":"27968_CR21","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1093\/jaoacint\/qsab058","volume":"104","author":"PB Prajapati","year":"2021","unstructured":"Prajapati, P. B., Jayswal, K. V. & Shah, S. A. DoE and risk-based DMAIC principle for implementation of enhanced analytical quality by design approach to a multipurpose-chromatography method for simultaneous Estimation of multiple fixed-dose combination products of aspirin. J. AOAC Int. 104, 1430\u20131441 (2021).","journal-title":"J. AOAC Int."},{"key":"27968_CR22","first-page":"1","volume":"11","author":"B \u017buromska-Witek","year":"2023","unstructured":"\u017buromska-Witek, B., Stolarczyk, M., Szl\u00f3sarczyk, M., Kielar, S. & Hubicka, U. Simple, accurate and multianalyte determination of thirteen active pharmaceutical ingredients in polypills by HPLC-DAD. Chemosensors 11, 1\u201314 (2023).","journal-title":"Chemosensors"},{"key":"27968_CR23","first-page":"205","volume":"9","author":"SM Chaudhari","year":"2018","unstructured":"Chaudhari, S. M., Prajapati, K. M., Luhar, S. V. & Narkhede, S. B. Rp-hplc method development and validation for simultaneous Estimation of atorvastatin, aspirin, Ramipril and Metoprolol succinate in tablet dosage form. Pharma Sci. Monit. 9, 205\u2013217 (2018).","journal-title":"Pharma Sci. Monit."},{"key":"27968_CR24","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/jssc.201500142","volume":"38","author":"E Peris-Garc\u00eda","year":"2015","unstructured":"Peris-Garc\u00eda, E., Ortiz\u2010Bolsico, C., Baeza\u2010Baeza, J. J. & Garc\u00eda\u2010Alvarez\u2010Coque, M. C. Isocratic and gradient elution in micellar liquid chromatography with Brij\u201035. J. Sep. Sci. 38, 2059\u20132067 (2015).","journal-title":"J. Sep. Sci."},{"key":"27968_CR25","doi-asserted-by":"publisher","first-page":"109334","DOI":"10.1016\/j.microc.2023.109334","volume":"194","author":"RA Sayed","year":"2023","unstructured":"Sayed, R. A., Mohamed, A. R., Shalaby, A. & Ibrahim, H. Innovative micellar-UPLC approach for concomitant determination of favipiravir and Remdesivir with four co-administered cardiovascular drugs in their pharmaceuticals and spiked plasma: greenness and whiteness assessment. Microchem. J. 194, 109334 (2023).","journal-title":"Microchem. J."},{"key":"27968_CR26","unstructured":"ICH. Q2A (R1. ). Validation of analytical procedures: text and methodology. International Conference on Harmonization. Geneva, Switzerland: IFPMA, (2005)."},{"key":"27968_CR27","unstructured":"FDA reviewer guidance. Validation of chromatographic methods, Center for drug evaluation and research, Washington, (1994)."},{"key":"27968_CR28","doi-asserted-by":"publisher","first-page":"117435","DOI":"10.1016\/j.trac.2023.117435","volume":"170","author":"MS Eissa","year":"2024","unstructured":"Eissa, M. S. & Darweish, E. Insights on ecological spectroscopic techniques recently adopted for pharmaceutical analysis: A comprehensive review from the perspective of greenness assessment metrics systems application. TrAC-Trends Anal. Chem. 170, 117435 (2024).","journal-title":"TrAC-Trends Anal. Chem."},{"key":"27968_CR29","doi-asserted-by":"publisher","first-page":"123551","DOI":"10.1016\/j.saa.2023.123551","volume":"305","author":"E Darweish","year":"2024","unstructured":"Darweish, E. & Mohamed, A. R. Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: tukey\u2019s test. Spectrochimica Acta - Part. A: Mol. Biomol. Spectrosc. 305, 123551 (2024).","journal-title":"Spectrochimica Acta - Part. A: Mol. Biomol. Spectrosc."},{"key":"27968_CR30","doi-asserted-by":"publisher","first-page":"122442","DOI":"10.1016\/j.saa.2023.122442","volume":"293","author":"R.A. Sayed","year":"2023","unstructured":"SayedR.A., MohamedA.R., Shalaby, A. & Ibrahim, H. Micellar-enhanced and green-assessed first-derivative synchronous spectrofluorimetric approach for concurrent determination of Alfuzosin hydrochloride and Solifenacin succinate in different matrices: Docking simulation. Spectrochimica Acta - Part. A: Mol. Biomol. Spectrosc. 293, 122442 (2023).","journal-title":"Spectrochimica Acta - Part. A: Mol. Biomol. Spectrosc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27968-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27968-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27968-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T13:16:08Z","timestamp":1769174168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27968-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27968"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27968-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3058"}}